Form 4: Halliburton Executive Sells 160,000 Shares Under 10b5-1 Plan
Insider Transaction Report
A Halliburton Co. executive, Richard Mark, President Western Hemisphere, sold 160,000 shares of common stock for $27.77 per share pursuant to a pre-arranged trading plan.
Summary
- Richard Mark, President Western Hemisphere of Halliburton Co. (HAL), disposed of 160,000 shares of common stock.
- The transaction occurred on November 12, 2025, at a price of $27.77 per share.
- The sale was executed under a Rule 10b5-1 trading plan adopted by Mr. Mark on August 13, 2025.
- Following the transaction, Mr. Mark beneficially owns 452,373.607 shares of common stock.
- His beneficial ownership includes 901.551 shares purchased through the Halliburton Company Employee Stock Purchase Plan for the period ending March 31, 2025.
- Beneficial ownership also includes 10,193.461 shares accumulated through dividend reinvestment as of September 30, 2025.
- Mr. Mark also holds several unexercised options to buy common stock, which were not part of this transaction.
Sentiment
Score: 5
Explanation: Neutral. The filing reports a routine insider transaction executed under a pre-arranged 10b5-1 trading plan, which is a common practice for executives to manage their equity holdings and diversify their portfolios. It does not indicate any specific positive or negative operational or financial news for the company.
Negatives
- An insider sale of 160,000 shares could be perceived negatively by some investors, although it was pre-planned.
Future Outlook
The filing does not contain any forward-looking statements or guidance beyond the execution of a pre-arranged trading plan.
Industry Context
This Form 4 filing details an individual executive's stock transaction and does not provide broader industry context or trends. Halliburton operates in the oilfield services industry, which is influenced by global energy demand and commodity prices.
Stakeholder Impact
- Shareholders: The sale by a high-ranking executive could be interpreted in various ways, from routine portfolio management to a signal about future company prospects, potentially influencing short-term sentiment. However, the pre-planned nature mitigates immediate concerns.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 01/04/2016 | Date exercisable for an option to buy common stock with an exercise price of $34.48, expiring 01/04/2026. |
| 01/03/2017 | Date exercisable for an option to buy common stock with an exercise price of $55.68, expiring 01/03/2027. |
| 01/02/2018 | Date exercisable for an option to buy common stock with an exercise price of $49.61, expiring 01/02/2028. |
| 12/20/2018 | Date exercisable for an option to buy common stock with an exercise price of $27.14, expiring 12/20/2028. |
| 03/31/2025 | End of period for which 901.551 shares were purchased through the Halliburton Company Employee Stock Purchase Plan. |
| 08/13/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 09/30/2025 | As of date for 10,193.461 shares accumulated through dividend reinvestment. |
| 11/12/2025 | Date of the reported transaction (sale of 160,000 shares). |
| 11/13/2025 | Date the Form 4 was filed. |
Recommendation
holdThis Form 4 filing details a pre-scheduled insider stock sale by a Halliburton executive. Such transactions, especially when executed under a Rule 10b5-1 plan, are generally considered routine for portfolio diversification and liquidity management and do not typically reflect a change in the executive's outlook on the company's fundamental performance. Therefore, this specific filing alone does not provide sufficient new information to warrant a change in investment recommendation. Investors should continue to 'hold' and evaluate the company based on its broader financial performance, industry trends, and strategic initiatives rather than this single insider transaction.
Keywords
Halliburton, HAL, Insider Sale, Form 4, Richard Mark, 10b5-1 Plan, Common Stock, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.